Results for tag: "Chemotherapy Induced Neutropenia Drug"

Chemotherapy Induced Neutropenia (CIN) is a type of immune disorder caused by chemotherapy treatments. It is characterized by a decrease in the number of neutrophils, a type of white blood cell, in the body. This can lead to an increased risk of infection and other complications. Treatment for CIN typically involves the use of drugs to boost the production of neutrophils. These drugs are known as granulocyte colony-stimulating factors (G-CSFs). The CIN drug market is composed of a variety of G-CSFs, including filgrastim, pegfilgrastim, and lenograstim. These drugs are used to stimulate the production of neutrophils and reduce the risk of infection. They are available in both injectable and oral forms. Additionally, some G-CSFs are available in combination with other drugs, such as antibiotics, to provide additional protection against infection. The CIN drug market is highly competitive, with several major players. These include Amgen, Novartis, Pfizer, and Teva Pharmaceuticals. Additionally, there are several smaller companies that specialize in the development and manufacture of G-CSFs. These include Biocon, Dr. Reddy's Laboratories, and Sun Pharmaceuticals. Show Less Read more